CLINICAL_TRIALS
trial_result
· 2018-02-19
Clinical Trial Update: Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients [NA]
Summary
A terminated clinical trial evaluating anti-platelet factor 4/heparin antibodies in hemodialysis patients with end-stage renal disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: W.L.Gore & Associates | Conditions: End Stage Renal Disease | NA | Status: TERMINATED | Results posted: 2018-02-19